FGF-23,左心室缩和慢性脏病患者的死亡率:与调解分析的重新访问
Naoko Hidaka1,2, Kosuke Inoue3, Hajime Kato1,2
1Division of Nephrology and Endocrinology, The University of Tokyo Hospital, Bunkyo, Tokyo, Japan.
JACC. Advances
|June 28, 2024
概括
纤维细胞生长因子 (FGF) -23有助于慢性病 (CKD) 患者的不良结果,左心室缩 (LVH) 介导了这一效应的一小部分. 需要进一步的研究来探索其他途径和FGF-23.3的负面影响.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 心脏病学 心脏病学
- 内分泌学 在内分泌学.
背景情况:
- 纤维细胞生长因子 (FGF) -23与慢性病 (CKD) 患者的不良结果和心血管疾病有关.
- 左心室缩 (LVH) 是一种可疑的机制,通过FGF-23发挥其有害作用.
研究的目的:
- 量化LVH在多大程度上调解FGF-23与CKD患者的不良长期结果之间的关系.
- 调查FGF-23水平与LVH,全因死亡率,心房动 (AF) 和充血性心力衰竭 (CHF) 之间的关联.
主要方法:
- 利用了来自CRIC队列研究中的2,368名CKD阶段2-4名参与者的数据.
- 使用线性和考克斯比例危险回归模型来评估关联.
- 在反事实框架内应用调解分析,以确定直接和间接的影响.
主要成果:
- 在FGF-23水平和LVH之间观察到正相关性.
- 升高的FGF-23与所有原因死亡率,AF和CHF风险增加有关.
- 在FGF-23对死亡率的影响中,LVH占7.4%,AF为11.2%,CHF为21.9%.
结论:
- 在CKD患者中,FGF-23对通过LVH的长期不良结果具有轻微的调解作用.
- 该研究强调,需要探索其他潜在的FGF-23作用的媒介.
- 进一步调查FGF-23的负面影响是有必要的.
相关概念视频
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
419
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
419
01:22Heart Failure Drugs: Diuretics
362
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
362
01:17Factors Affecting Renal Clearance: Renal Impairment
81
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
81
01:17Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K